Naga MounikaDrug Product · Validation · CMC
Menu
Working document

Single-Source and Long-Lead Raw Material Contingency Plan

A plug-and-play plan for inventorying single-source and long-lead raw materials feeding a PPQ campaign, comparing replacement lead time against actual schedule margin, and naming the triggered contingency for each, with a filled specimen.

Document typePlan
Topic areaProcess Validation
LevelAdvanced
UpdatedOctober 2026
How to use this document

Copy the template below into your quality system. Replace every <<FILL: ...>> placeholder with your company, system, and process specifics, then route it through your own document control, review, and approval. The filled specimen shows one worked example; adapt the numbers and scope to your operation and verify each cited regulation or standard against the current source before you rely on it.

This is a generic, originally worded starting point. It contains no confidential, proprietary, or employer material, it is drafted with AI assistance and reviewed, it is not legal or compliance advice, and adopting it does not by itself create or prove compliance. See the Disclaimer and Terms.

This is a ready-to-use contingency plan for every raw material feeding a PPQ campaign that is single-sourced, long-lead, or both. “Released with margin” answers the inventory question; this plan answers the risk question underneath it: what happens to the schedule if the material on hand fails, and is there a documented, triggered response rather than an assumption that it will not. Complete it before the CDMO slot or manufacturing date is committed. Replace every <<FILL: ...>> placeholder with your own specifics and route it through your normal document control, review, and approval. A worked filled specimen follows.

Document control header

FieldEntry
Document titleSingle-Source and Long-Lead Raw Material Contingency Plan for <<FILL: product / process>>
Document number<<FILL: e.g. PLN-RM-008>>
Linked PPQ protocol or CDMO slot readiness log<<FILL: ref>>
Document owner<<FILL: e.g. Supply Chain / Procurement>>

1. Scope

DimensionDecision
Product / process / campaign in scope<<FILL>>
Materials inventoried<<FILL: every raw material, resin, buffer component, or biological ancillary reagent feeding the process>>
Out of scope<<FILL: e.g. materials with two or more qualified sources and routine lead times, not carried into this plan's contingency section>>

2. Approach

Inventory every material feeding the process. For each, determine whether it is single-sourced (one qualified supplier or source) and whether it is long-lead (replacement lead time material relative to the campaign’s own schedule margin). A material that is both carries compounding risk and gets a full contingency entry below; a material with two or more qualified sources, or with a short replacement lead time comfortably inside the schedule margin, is logged but does not require a full contingency.

3. Risk basis

QuestionHow it is answered
Is this material single-sourced?Confirmed against the approved vendor list; a second listed vendor not actually qualified for this specific grade or specification does not count as a second source
What is the replacement lead time?Time to obtain an emergency lot from the same source, or to qualify and receive from a backup source, whichever is the realistic path
Does the schedule have margin to absorb that lead time if the material on hand fails?Compare the lead time against the actual calendar margin before the booked manufacturing or CDMO date, not against a generic assumption of flexibility
Was this material’s lot-to-lot variability characterized across more than one lot during Stage 1?If No, this is also an open process-characterization gap, not only a supply-chain one, and should be flagged back to that prerequisite

4. Material inventory and contingency

MaterialSingle-sourced?Replacement lead timeSchedule margin availableCharacterized across multiple lots?Contingency and trigger
<<FILL>><<FILL: Yes/No>><<FILL>><<FILL>><<FILL: Yes/No>><<FILL: backup source, emergency-lot path, and the specific trigger, e.g. a failed incoming lot or a disclosed vendor supply disruption>>
<<FILL>><<FILL>><<FILL>><<FILL>><<FILL>><<FILL>>

5. Roles

RoleResponsibility
Supply chain / procurementOwns the material inventory, lead-time assessment, and backup-source qualification status
Manufacturing science / process developmentConfirms whether a flagged material’s lot-to-lot variability is adequately characterized, and feeds an open gap back to process characterization
Validation leadConfirms this plan is closed as part of the PPQ readiness review before protocol approval
Quality AssuranceApproves the contingency plan and any risk acceptance where no schedule margin exists

6. Schedule

MilestoneTarget date
Material inventory completed<<FILL>>
Lead-time assessment completed for every single-source or long-lead item<<FILL>>
Contingency and trigger documented for every flagged item<<FILL>>
Plan reviewed and closed ahead of PPQ readiness review<<FILL>>

7. Acceptance

FieldEntry
Every single-source or long-lead material has a documented contingency and trigger<<FILL: Yes/No>>
Any item with no schedule margin and no contingency<<FILL: list, with QA risk-acceptance decision, or confirm none exist>>
Approved by (QA, name, date)<<FILL>>

8. References

See the paired article, PPQ readiness: the prerequisites that decide success before batch one, for the reasoning behind treating raw material risk as more than an inventory question. 21 CFR 211.84, testing and approval or rejection of components, drug product containers, and closures. The paired CDMO PPQ slot readiness log, where this plan’s conclusion feeds the material-release readiness check.

9. Revision history

VersionDateAuthorSummary of change
<<FILL: 1.0>><<FILL>><<FILL>>Initial issue.

10. Approvals

RoleNameSignatureDate
Author (Supply Chain / Procurement)<<FILL>>
Reviewer (Manufacturing Science)<<FILL>>
Approver (QA)<<FILL>>

Filled specimen

Extract for a monoclonal antibody drug substance process ahead of a commercial PPQ campaign at a CDMO, booked slot ten weeks out.

MaterialSingle-sourced?Replacement lead timeSchedule margin availableCharacterized across multiple lots?Contingency and trigger
Protein A chromatography resinYes, one qualified vendor and grade14 weeks for an emergency lot10 weeks before the booked slotYes, across 3 lots during Stage 1Flagged as a schedule-critical gap: no contingency closes a 4-week shortfall by material substitution alone; QA and the validation lead agreed to move the booked slot 5 weeks to restore margin rather than accept the risk
Cell culture basal medium, custom formulationYes, one qualified contract manufacturer6 weeks10 weeksYes, across 2 lots during Stage 1Contingency: expedited reorder triggered at incoming receipt if the lot on hand fails release testing; 4 weeks of schedule margin remains after the lead time, accepted without further action
Sodium chloride, USP gradeNo, two qualified vendors2 weeks10 weeksNot applicable, compendial commodity materialLogged, no contingency required

Disposition: the Protein A resin was the only item in this inventory where lead time exceeded schedule margin; moving the slot, rather than accepting the risk, was the decision QA and the validation lead made, consistent with the PPQ readiness article’s rule that a gap with no margin requires either closing the gap, moving the date, or a documented risk acceptance, never silence.

Common inspection findings this plan prevents

  • A single-source material’s replacement lead time never compared against the campaign’s actual schedule margin, discovered only when the lot on hand fails.
  • “Released with margin” confirmed as inventory on hand with no documented contingency for what happens if the next lot fails.
  • A raw material flagged as single-source but never cross-checked against whether its lot-to-lot variability was actually characterized during Stage 1.
  • A schedule risk identified informally in a hallway conversation with no documented decision to close it, move the date, or accept it.

How to adapt this plan

  1. Inventory every material feeding the process, not only the ones already suspected to be a risk; a second-sourced material can still be long-lead.
  2. Compare lead time against the actual calendar margin before the booked date, not a generic assumption of schedule flexibility.
  3. Where a flagged material was characterized across only one lot, route that finding back to the process characterization prerequisite, not only to this plan’s contingency column.
  4. Close this plan before the CDMO slot or manufacturing date is treated as committed, consistent with the CDMO logistics discipline in the paired article.
Add this site to your home screen Full screen, works offline, one tap from your home screen.